However, certainly additional analyses in preclinical models of AML including sophisticated mouse models that enable a better understanding of the functional role of CD105 are required to provide a broader basis for potential future clinical studies that might ultimately improve treatment of AML. The gene discussed is ENG; the disease is acute myeloid leukemia.